Related Articles
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer
Genetic basis of a common tumor origin in the development of pancreatic mixed acinar‑neuroendocrine‑ductal carcinoma: A case report
Synchronous primary colorectal mucinous adenocarcinoma and pancreatic ductal adenocarcinoma: A case report
A spindle cell anaplastic pancreatic carcinoma with rhabdoid features following curative resection
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: A single institution retrospective review